Growth Metrics

Avanos Medical (AVNS) Divestments (2018 - 2024)

Avanos Medical recorded quarterly Divestments of -$2.1 million in Q4 2024, down 200.0% quarter-over-quarter from $2.1 million in Q1 2024, and down 102.36% year-over-year from $89.0 million in Q1 2024.

Avanos Medical's Divestments history runs 3 years deep, the most recent figure standing at -$2.1 million for Q4 2024.

  • In Q4 2024, Divestments fell 102.36% year-over-year to -$2.1 million; the TTM figure through Sep 2025 stood at -$2.1 million (down 102.31% YoY), while the FY2023 annual figure was $89.0 million, changed N/A from the prior year.
  • Divestments came in at -$2.1 million for Q4 2024 at Avanos Medical, down from $2.1 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $89.0 million in Q4 2023 to a low of -$2.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -2.10 Mn
Mar 31, 2024 2.10 Mn
Dec 31, 2023 89.00 Mn
Sep 30, 2018 19.80 Mn